These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hemolytic-uremic syndrome associated with an infection by verotoxin producing Escherichia coli 0111 in a woman on oral contraceptives. Stenger KO, Windler F, Karch H, von Wulffen H, Heesemann J. Clin Nephrol; 1988 Mar; 29(3):153-8. PubMed ID: 3282732 [Abstract] [Full Text] [Related]
3. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Ake JA, Jelacic S, Ciol MA, Watkins SL, Murray KF, Christie DL, Klein EJ, Tarr PI. Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195 [Abstract] [Full Text] [Related]
4. Relationship between susceptibility to hemolytic-uremic syndrome and levels of globotriaosylceramide in human sera. Watarai S, Yokota K, Tana, Kishimoto T, Kanadani T, Taketa K, Oguma K. J Clin Microbiol; 2001 Feb; 39(2):798-800. PubMed ID: 11158156 [Abstract] [Full Text] [Related]
5. Association between hemolytic uremic syndrome and verotoxin-producing strains of E. coli. Jure MA, de Saab OA, de Castillo MC, Sesma F, Miceli S, Zamora AM, de Ruiz Holgado AP, de Nader OM. Rev Latinoam Microbiol; 1998 Feb; 40(1-2):1-8. PubMed ID: 10932728 [Abstract] [Full Text] [Related]
6. Role of non-polio enterovirus infection in pediatric hemolytic uremic syndrome. De Petris L, Gianviti A, Caione D, Innocenzi D, Edefonti A, Montini G, De Palo T, Tozzi AE, Caprioli A, Rizzoni G. Pediatr Nephrol; 2002 Oct; 17(10):852-5. PubMed ID: 12376816 [Abstract] [Full Text] [Related]
8. Endemic Esherichia coil O157:H7 infections and hemolytic-uremic syndrome in Oklahoma, 2002-2005. Karpac CA, Lee A, Kunnel BS, Bamgbola OF, Vesely SK, George JN. J Okla State Med Assoc; 2007 Nov; 100(11):429-33. PubMed ID: 18183860 [Abstract] [Full Text] [Related]
9. Association of verotoxin-producing E. coli and verotoxin with hemolytic uremic syndrome. Arbus GS. Kidney Int Suppl; 1997 Mar; 58():S91-6. PubMed ID: 9067954 [Abstract] [Full Text] [Related]
10. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006. Espié E, Grimont F, Mariani-Kurkdjian P, Bouvet P, Haeghebaert S, Filliol I, Loirat C, Decludt B, Minh NN, Vaillant V, de Valk H. Pediatr Infect Dis J; 2008 Jul; 27(7):595-601. PubMed ID: 18520972 [Abstract] [Full Text] [Related]
12. Changes in the postenteropathic form of the hemolytic uremic syndrome in children. Coad NA, Marshall T, Rowe B, Taylor CM. Clin Nephrol; 1991 Jan; 35(1):10-6. PubMed ID: 1801761 [Abstract] [Full Text] [Related]
14. Does blood type B protect against haemolytic uraemic syndrome? An analysis of the 1996 Sakai outbreak of Escherichia coli O157:H7 (VTEC O157) infection. The Osaka HUS Critical Care Study Group. Shimazu T, Shimaoka M, Sugimoto H, Taenaka N, Hasegawa T. J Infect; 2000 Jul; 41(1):45-9. PubMed ID: 10942639 [Abstract] [Full Text] [Related]
19. [Hemolytic uremic syndrome associated to shigatoxin producing Escherichia coli in Chilean children: clinical and epidemiological aspects]. Prado J V, Cavagnaro S M F, Grupo de Estudio de Infecciones por STEC. Rev Chilena Infectol; 2008 Dec; 25(6):435-44. PubMed ID: 19194606 [Abstract] [Full Text] [Related]
20. Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome. Zimmerhackl LB, Besbas N, Jungraithmayr T, van de Kar N, Karch H, Karpman D, Landau D, Loirat C, Proesmans W, Prüfer F, Rizzoni G, Taylor MC, European Study Group for Haemolytic Uraemic Syndromes and Related Disorders. Semin Thromb Hemost; 2006 Mar; 32(2):113-20. PubMed ID: 16575686 [Abstract] [Full Text] [Related] Page: [Next] [New Search]